Ralitoline and CI-953 are anticonvulsant compounds active in both maximal electroshock and kindling models of seizures with rodents. CI-953 (IC,, = 5 PM) and ralitoline (IC, = 2pM) both blocked sustained repetitive firing of sodium action potentials with effects on firing activity triggered by spontaneous excitatory postsynaptic potentials at higher concentrations. No effects on iontophoretic GABA and glutamate responses were noted. Both compounds inhibited the binding of tritiated batrachotoxinin A 20-a-benzoate ([3H]BTX-b) to rat brain synaptosomes with apparent K,, values of 29pM (CI-953) and 25 PM (ralitoline). Our results suggest that effects on voltage-dependent sodium channels may underlie the anticonvulsant action of these compounds.
INTRODUCTION
Ralitoline (CI-946) and CI-953 ( Fig. 1) are structurally related compounds with efficacy in preclinical anticonvulsant models. Both compounds potently prevent maximal electroshock-induced seizures in rats and mice when given orally and they also raise afterdischarge thresholds in kindled rats. However, neither compound pre-vents clonic seizures from a variety of chemical convulsant agents in mice (bicuculline, pentylenetetrazol, strychnine, picrotoxin)1,'5Y23. This profile of anticonvulsant activity is similar to those of phenytoin and carbamazepine', standard anticonvulsant compounds used in the treatment of generalized tonic-clonic and partial seizures in man.
Both phenytoin and carbamazepine prevent trains of rapidly repeated sodium action potentials in vitro from sustained depolarization"~'2 and there is now considerable evidence that they may exert their anticonvulsant effects by acting at voltage-sensitive sodium channels involved in the initiation and propagation of action potentials in the brain*~10~'4~17~20-22~24~27. In addition, phenytoin and carbamazepine inhibit the binding of tritiated batrachotoxinin A 20-a-benzoate (BTX-b), a ligand for a specific site on voltage-dependent sodium channels that is associated with anticonvulsant and local anesthetic action5 '26,28 . The following studies were undertaken to determine if ralitoline and CI-953 share similar effects to those of phenytoin and carbamazepine on repetitive action potentials and on BTX-b binding. Preliminary results of some of these studies were presented in abstract form23.
MATERIALS AND METHODS

Electrophysiological experiments
Cultures of fetal mouse spinal cord neurons were prepared by standard methods18. For electrophysiological experiments, cultures were placed on the heated stage of an inverted phase contrast microscope and intracellular impalements were obtained with high-resistance glass micropipettes (20-60 MQ) filled with either 4 M potassium acetate or 3 M KCl. Membrane potential was recorded with a conventional high-impedance bridge amplifier and displayed on a rectilinear recorder and recorded on tape. The experimental medium was Dulbecco's phosphate-buffered saline (DPBS: NaCl137 mM/KC13 mM/N%HPO, 8 mM/KH2P04 1.5 mM/MgCl, 1 mM (spontaneous activity experiments) or substituted with 10 mM MgCl, (repetitive firing and iontophoretic experiments)/CaCl, 1 mM/o-glucose 10 mM, pH 7.3-7.4).
Samples of CI-953 and ralitoline were obtained from Parke-Davis Research. Concentrations of ralitoline and CI-953 are expressed as the equivalent concentration of free base or acid and were dissolved into dimethyl sulfoxide (DMSO) and added to the bath to achieve the desired concentration. In each case, final concentration of DMSO was not greater than 0.1% . Previous control experiments with concentrations of DMSO up to 1.0% showed no change in sustained firing, GABA or glutamate responses (data not shown). The bathing medium was static and was maintained at temperatures between 35-37 "C.
Tests were performed to determine the effect of ralitoline and U-953 on sustained repetitive firing of sodium action potentials, spontaneous neuronal activity and postsynaptic GABA and glutamate responses. Methods are identical to those of Rock et a1. 19 . IC,, values for repetitive firing and spontaneous activity experiments were obtained by probit analysis and significant differences from control (P < 0.05) determined by a Wilcoxon ranksum test. In iontophoretic experiments, significant difference from predrug application was determined by a 2-tailed Student's t-test. 
RESULTS
In control conditions, mouse spinal cord neurons respond to increasing amplitude 450 msec depolarizing current steps with trains of sodium action potentials that increase in frequency with larger amplitude current steps (Fig. 2, left cells to fire sustained high frequency action potentials. Both CI-953 ( Fig. 3A ; IC, = 5 PM) and ralitoline ( Fig. 3B ; ICs, = 2 PM) reduced the percentage of cells that exhibited sustained repetitive firing of sodium action potentials in a concentrationdependent manner. Higher concentrations of both compounds were required to reduce spontaneous synaptically driven action potentials (Fig. 3) . ( Table I) Table III in comparison to published valuesz6 for phenytoin and carbamazepine.
DISCUSSION
Concentrations of drug in plasma were calculated from pharmacokinetic data for doses (ED,,) that protect rats or mice from maximal electroshock tonic extensor seizures7. These data are shown for CI-953, ralitoline, phenytoin and carbamazepine in Tables I and II trations. Similar calculations for phenytoin and carbamazepine from the maximal electroshock model with rats9 agree well with clinical reports that unbound therapeutic concentrations are from 4-8 ,&I for phenytoin and 3-12.5 ,uM for carbamazepine2.
At concentrations of CI-953 or ralitoline well above the 'therapeutic levels' shown in Table I , no effects on electrophysiological responses to GABA, a major inhibitory neurotransmitter, or the excitatory neurotransmitter glutamate, were noted. polarization of cultured spinal cord neurons is similar to results obtained with phenytoin and carbamazepine'1,'2 and also similar to results with valproate13 and zonisamide lg. All of the drugs that inhibit sustained firing in vitro also prevent tonic extensor seizures from maximal electroshock in rats, and all except valproate have been shown electrophysiologically and by displacement of batrachotoxinin binding to interact with voltage-sensitive sodium channels.
The inhibitory action of CI-953 and ralitoline on rapid trains of action potentials from sustained deBoth phenytoin and carbamazepine in many different voltage clamp preparations have been shown to reduce voltage-dependent inward sodium currents and to shift the voltage dependence of A recent analysis of the action of phenytoin at single sodium channels has shown that phenytoin interacts with both inactivated and resting sodium channels17. It has been postulated that these changes in sodium conductance lead to the eventual blockade of sodium action potentials, especially during high frequency firing and sustained depolarizations such as those seen during seizures.
The displacement of BTX-b binding by CI-953 and ralitoline indicates that these drugs modulate binding of neurotoxins to receptor site 2 on sodium channels. This site is highly sensitive to the conformational state of the sodium channel protein and numerous neurotoxins, insecticides, local anesthetics, antiarrhythmic drugs and anticonvulsants alter neurotoxin binding by indirect allosteric interactions5. 26 . Analysis of the competition of binding interactions between carbamazepine and the local anesthetic lidocaine indicates a common site of interaction at the receptoti8. The binding results extend the association previously made between anticonvulsant activities and allosteric inhibition of BTX-b binding26. Table III compares the concentrations of anticonvulsants inhibiting BTX-b binding with unbound plasma concentrations achieved during prevention of seizures in rodents (Bockbrader and VonHodenberg, unpublished observations) or therapeutic concentrations in clinical studies with phenytoin and carbamazepine. Phenytoin, carbamazepine and CI-953 each occupy between 13% and 33% of sodium channel sites at therapeutic concentrations. Ralitoline occupied approximately 4% of sodium channel sites. Other anticonvul-sants (valproate, phenobarbital, diazepam) had little effect on BTX-b binding at therapeutic concentrations26. The actual occupancy of these lipophilic drugs may be higher, since they may significantly partition into brain membranes and increase concentration at sodium channels. Moreover, since inhibition of sodium channels is strongly frequency and voltage dependent'0~'7~21~27, the effective K,, in an epileptic focus may be more potent than in binding experiments with synaptosomes. It will be interesting to examine the frequency and voltage dependence of CI-953 and ralitoline for inhibition of voltage-clamped sodium currents.
In summary, our results show inhibition of sustained repetitive action potentials from neuronal membrane depolarization and also inhibition of BTX-b binding from rat synaptosomal membranes by both CI-953 and ralitoline at concentrations that are relevant for the anticonvulsant actions of these compounds in animals. We conclude that the anticonvulsant mechanism of these two compounds is likely to be very similar to that of phenytoin and carbamazepine, and may involve modulation of neuronal voltage-sensitive sodium channels.
